Khozeimeh Faezeh, Ziaei Samaneh, Khalesi Saeedeh, Allameh Maryam, Jahanshahi Gholamreza
DDS, MS; Associate Professor, Dental Research Center, Dept. of Oral Medicine, Dental Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
DDS, MS; Assistant Professor, Dept. of Oral and Maxillofacial Medicine, Faculty of Dentistry, Shahrekord branch, Shahrekord, Iran.
J Clin Exp Dent. 2019 Jul 1;11(7):e587-e592. doi: 10.4317/jced.54425. eCollection 2019 Jul.
Photodynamic therapy (PDT) using 5-aminolevulinic acid (ALA) has previously shown promising results in cancerous cell destruction. The present study was conducted to evaluate the efficacy of this treatment option on oral epithelial dysplasia in Wistar rats. Furthermore, microscopic effects of systemic versus topical administration of ALA before laser illumination was assessed.
Thirty male Wistar rats (200- 250 grams) were used in the present study. Tongue dysplasia was induced by a daily delivery of a 20 ppm solution of 4-nitroquinoline -1- oxide (4NQO) for 3 months. Then, rats were divided into 3 groups of 10 including, group 1 that was received systemic ALA-based PDT (30 mg/kg ALA), group 2 that was received topical ALA-based PDT (20% ALA solution) and group 3 (control) which was left untreated. Tongue specimens were fixed for histopathological evaluation and dysplasia was graded at microscopic level. Data was compared between various treatment groups using Mann Whitney test (<0.05).
The rate of atypical dysplastic cells was decreased significantly in both topical (= 0.006) and systemic (= 0.001) treatment groups compared to control group. Furthermore, systemic use of ALA resulted in a remarkable destruction of dysplastic cells compared to its topical application (=0.045). Nevertheless, some evidence of muscle destruction was documented in systemic ALA group.
It seems that ALA mediated PDT is an effective treatment option for the destruction of dysplastic cells. However, the extent of this effect depends on the mode of ALA administration before light illumination. Photodynamic therapy, 5-aminolevulinic acid, Dysplasia, Potentially malignant disorders.
先前使用5-氨基酮戊酸(ALA)的光动力疗法(PDT)在癌细胞破坏方面已显示出有前景的结果。本研究旨在评估该治疗方案对Wistar大鼠口腔上皮发育异常的疗效。此外,还评估了激光照射前全身给药与局部给药ALA的微观效果。
本研究使用了30只雄性Wistar大鼠(体重200 - 250克)。通过每日给予20 ppm的4-硝基喹啉-1-氧化物(4NQO)溶液持续3个月诱导舌部发育异常。然后,将大鼠分为3组,每组10只,包括:第1组接受基于全身ALA的PDT(30 mg/kg ALA),第2组接受基于局部ALA的PDT(20% ALA溶液),第3组(对照组)不进行治疗。将舌部标本固定用于组织病理学评估,并在显微镜下对发育异常进行分级。使用Mann Whitney检验(<0.05)比较各治疗组之间的数据。
与对照组相比,局部(= 0.006)和全身(= 0.001)治疗组的非典型发育异常细胞率均显著降低。此外,与局部应用相比,全身使用ALA导致发育异常细胞的显著破坏(=0.045)。然而,在全身ALA组中记录到了一些肌肉破坏的证据。
似乎ALA介导的PDT是破坏发育异常细胞的有效治疗方案。然而,这种效果的程度取决于光照前ALA的给药方式。光动力疗法、5-氨基酮戊酸、发育异常、潜在恶性疾病。